Dube Michael P

EDGAR CIK 0002019493

Intellia Therapeutics, Inc. - NTLA

  1. Manufacturing
  2. Chemicals
  3. In Vitro & In Vivo Diagnostic Substances
Officer
VP, Chief Accounting Officer
Direct Buys
0
$0
0 Shares
Direct Sells
3
($74,134)
-5,746 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
10/01/2025
10/03/2025
Sell
-1,871 @ $17.38
 ($32,518) 55,266 (-3.27%) Direct
07/02/2025
07/03/2025
Sell
-2,503 @ $9.95
 ($24,905) 57,137 (-4.20%) Direct
01/03/2025
01/07/2025
Sell
-1,372 @ $12.18
 ($16,711) 45,640 (-2.92%) Direct